CClinicalTrials.gg
Status unknownNCT02187666Updated Jul 11, 2014

NOC2 Spine Registry

An observational study in Spinal Disease, sponsored by DC2 Healthcare. Status unknown at 1 site in United States. Per ClinicalTrials.gov, last updated 2014-07-11.

Sponsored by DC2 Healthcare · Observational

The sponsor has not verified this record recently (last verified Jul 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10,000
Sex
All
01

Study summary

The primary objective of the Spine Registry is to enhance the understanding of spinal disease and treatment of spinal disease with the goal of guiding treatment options.

Read the detailed description

This study will enhance the understanding of the variability, progression and treatment of spinal disease with the ultimate goal of better guiding and assessing therapeutic intervention. Researchers will collect complications and safety following cervical and lumbar surgeries to determine best options for patients. Prospective reports will be collected on patients undergoing lumbar or cervical spinal surgery. Patients will be enrolled in registry after signing informed consent. Data will be collected at various time points. The registry will serve as a database of cervical and lumbar surgeries in which retrospective analysis and exploratory analysis of specific research questions can be answered.

02

Conditions studied

  • Spinal Disease

Browse trials for

Keywords

  • Cervical
  • Lumbar
  • Spine
  • Spinal Disease
03

In context

Spinal Diseases

267 studies on the registry are indexed under Spinal Diseases; 54 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 108 across 87 observational studies indexed under Spinal Diseases.

Browse Spinal Diseases studies →

Lead sponsor

DC2 Healthcare is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Approximately 10,000 patients undergoing lumbar or cervical surgery will be screened to decide whether they meet the inclusion and exclusion criteria of the study/patient registry. Patients who meet the study criteria will be informed by the investigator and should read the 'patient information' document. Patients must give their written informed consent to be enrolled into this study.

Inclusion criteria

  • Patients undergoing lumbar or cervical surgery
  • Understand and sign informed consent

Exclusion criteria

Exclusion Criteria:

  • There are no specific exclusion criteria
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10,000 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Groups and cohorts

  • Lumbar

    Patients undergoing lumbar spinal surgery

  • Cervical

    Patients undergoing cervical spine surgery

06

What researchers measure

Primary outcomes

  1. Change in Visual Analogue Scale (VAS) from baseline at 4 weeks

    Pain intensity scale taken at baseline and 4 weeks after surgery

    Time frame: baseline and 4 weeks after surgery

  2. Change in Visual Analogue Scale (VAS) from baseline at 3 months

    Pain intensity scale taken at baseline and 3 months after surgery

    Time frame: baseline and 3 months after surgery

  3. Change in Visual Analogue Scale (VAS) from baseline at 6 months

    Pain intensity scale taken at baseline and 6 months after surgery

    Time frame: baseline and 6 months after surgery

  4. Change in Visual Analogue Scale (VAS) from baseline at 12 months

    Pain intensity scale taken at baseline and 12 months after surgery

    Time frame: baseline and 12 months after surgery

  5. Change in Visual Analogue Scale (VAS) from baseline at 24 months

    Pain intensity scale taken at baseline and 24 months after surgery

    Time frame: baseline and 24 months after surgery

Secondary outcomes

  1. Change from baseline in Oswestry Disability index at 4 weeks

    Assesses impact of disability in terms of activities of daily living. To be taken at baseline and 4 weeks after surgery.

    Time frame: baseline and 4 weeks after surgery

  2. Fusion at 6 months

    Time frame: 6 months post-op

  3. Length of hospital stay

    Date of discharge will be recorded, an average of one to three days

    Time frame: one to three days following surgery

  4. Revision surgery within 30 days

    Time frame: 30 days after surgery

  5. Return to work

    Time off of work and whether patient returned restricted or unrestricted

    Time frame: 4 weeks after surgery

  6. Return to normal/usual activity

    Time between surgery and resuming normal activity for patient

    Time frame: 4 weeks after surgery

  7. Complications

    Time frame: 24 hours after surgery

  8. Change from baseline in Oswestry Disability index at 3 months

    Assesses impact of disability in terms of activities of daily living. To be taken at baseline and 3 months after surgery.

    Time frame: baseline and 3 months after surgery

  9. Change from baseline in Oswestry Disability index at 6 months

    Assesses impact of disability in terms of activities of daily living. To be taken at baseline and 6 months after surgery.

    Time frame: baseline and 6 months after surgery

  10. Change from baseline in Oswestry Disability index at 12 months

    Assesses impact of disability in terms of activities of daily living. To be taken at baseline and 12 months after surgery.

    Time frame: baseline and 12 months after surgery

  11. Change from baseline in Oswestry Disability index at 24 months

    Assesses impact of disability in terms of activities of daily living. To be taken at baseline and 24 months after surgery.

    Time frame: baseline and 24 months after surgery

  12. Return to work

    Time off of work and whether patient returned restricted or unrestricted

    Time frame: 3 months after surgery

  13. Return to work

    Time off of work and whether patient returned restricted or unrestricted

    Time frame: 6 months after surgery

  14. Return to work

    Time off of work and whether patient returned restricted or unrestricted

    Time frame: 12 months after surgery

  15. Return to work

    Time off of work and whether patient returned restricted or unrestricted

    Time frame: 24 months after surgery

  16. Return to normal/usual activity

    Time between surgery and resuming normal activity for patient

    Time frame: 3 months after surgery

  17. Return to normal/usual activity

    Time between surgery and resuming normal activity for patient

    Time frame: 6 months after surgery

  18. Return to normal/usual activity

    Time between surgery and resuming normal activity for patient

    Time frame: 12 months after surgery

  19. Return to normal/usual activity

    Time between surgery and resuming normal activity for patient

    Time frame: 24 months after surgery

  20. Complications

    Time frame: 4 weeks after surgery

  21. Complications

    Time frame: 3 months after surgery

  22. Complications

    Time frame: 6 months after surgery

  23. Complications

    Time frame: 12 months after surgery

  24. Complications

    Time frame: 24 months after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02187666
Lead sponsor
DC2 Healthcare
Collaborators
National Neurosurgical and Orthopedic Optimum Care Continuum (NOC2), National Research Independent Operations Management
Responsible party
Sponsor
First posted
Jul 11, 2014
Start date
Dec 2011
Primary completion
Dec 2016 (estimated)
Last update
Jul 11, 2014

Study contacts

Christina R Cook, PhD
Contact
ccook@dc2healthcare.com
615-712-9574
Risa Tyo, PharmD
Contact
rtyo@dc2healthcare.com
615-712-9574

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion